Supportive care is becoming essential to modern oncology strategy, helping address patients’ emotional, physical, financial, and treatment-related needs to improve outcomes, reduce costs, and enhance the care experience.

Emerging front-line chronic lymphocytic leukemia (CLL) treatment options combine covalent BTK inhibitors with venetoclax and obinutuzumab, prompting new considerations around clinical benefit, risk, and cost compared with existing standards of care.

Health insurance premiums are projected to see their largest increase in 15 years — and rising cancer rates among working-age adults are partly to blame. Here’s how prevention and utilization management can help keep healthcare sustainable.

Malnutrition in cancer care is more than a clinical issue; it’s a financial one. Here are three areas where malnutrition has the biggest financial impact on patients and health plans.

When we talk about “toxicity” in cancer care, most think of the physical side effects of treatment. But there’s another form that can be just as devastating: financial toxicity.